The forecast for chronic liver diseases and cirrhosis mortality among females in Canada predicts a gradual year-on-year increase in the rates from 2024 to 2028. Starting at 7.5 deaths per 100,000 women in 2024 and rising to 7.9 by 2028, the figures indicate a steady upward trend. While year-on-year projections reveal consistent 1.3% increases, the compound annual growth rate (CAGR) over this period is approximately 1.3% as well.
Looking ahead, factors to watch include the impact of healthcare advancements, public health initiatives, and lifestyle changes on these mortality rates. Continual monitoring of alcohol consumption and hepatitis infection rates will be vital for future forecasts.
